Paul Awolade

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Breast Cancer Cells

Dna Damage Response

Top Venues

International journal of molecular sciences

ACS medicinal chemistry letters

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Sala, Hector Esquer, Timothy Kellett, Jeffrey T Kearns, Paul Awolade, Qiong Zhou, Daniel V LaBarbera
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos. International journal of molecular sciences 25 (16) (2024)
Rita Sala, Hector Esquer, Timothy Kellett, Jeffrey T Kearns, Paul Awolade, Qiong Zhou, Daniel V LaBarbera
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos. International journal of molecular sciences 25 (16) (2024)
Carita Sallomy, Paul Awolade, Minna Rahnasto-Rilla, Mari Hämäläinen, Liisa P Nousiainen, Niklas G Johansson, Sanna Hiltunen, Petri A Turhanen, Eeva Moilanen, Maija K Lahtela-Kakkonen, Juri M Timonen
TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives. ACS medicinal chemistry letters 15 (8) (2024)
Carita Sallomy, Paul Awolade, Minna Rahnasto-Rilla, Mari Hämäläinen, Liisa P Nousiainen, Niklas G Johansson, Sanna Hiltunen, Petri A Turhanen, Eeva Moilanen, Maija K Lahtela-Kakkonen, Juri M Timonen
TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives. ACS medicinal chemistry letters 15 (8) (2024)
Brett J Prigaro, Hector Esquer, Qiong Zhou, Laura A Pike, Paul Awolade, Xin-He Lai, Adedoyin D Abraham, Joshua M Abbott, Brock Matter, Uday B Kompella, Wells A Messersmith, Daniel L Gustafson, Daniel V LaBarbera
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. Journal of medicinal chemistry 65 (5) (2022)
Nosipho Cele, Paul Awolade, Pule Seboletswe, Kolawole A Olofinsan, Md Shahidul Islam, Parvesh Singh
α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
null Shalini, null Pankaj, Sourav Taru Saha, Mandeep Kaur, Ebenezer Oluwakemi, Paul Awolade, Parvesh Singh, Vipan Kumar
Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation. RSC advances 10 (27) (2020)